诊断时年龄对子宫内膜癌患者种族差异的影响
基于1991至2010年监测、流行病学和最终结果(SEER)数据库中78,184例白人及8518例黑人子宫内膜癌患者,评估诊断年龄与种族在疾病表现和结局中的交互作用。黑人患者中非子宫内膜样组织学随年龄增加更明显,年轻患者中种族生存差异更大,TP53、PTEN突变及三种侵袭性分子亚型随种族、年龄和组织学而异。
要点
- 黑人子宫内膜癌患者诊断年龄中位数较白人患者年轻3岁(浆液性癌和癌肉瘤,P<0.0001)。
- 非子宫内膜样组织学随年龄增加在黑人与白人患者间的差异更大(P<0.0001)。
- 生存和癌症相关死亡的种族差异在年轻患者中比老年患者更普遍(P<0.0001)。
核心结论
- 侵袭性组织学和分子特征在黑人和高龄患者中更常见,年龄对不良肿瘤特征的影响在黑人与白人患者间的差异更大。
- 结局的种族差异在年轻患者中更大,作者认为早期干预可能减轻子宫内膜癌的种族差异。
研究设计与样本
- 研究评估了1991至2010年间诊断为子宫内膜癌的女性,数据来自监测、流行病学和最终结果(SEER)数据库。
- TP53或PTEN突变状态以及侵袭性整合型、基于转录组的或基于体细胞拷贝数改变的分子亚型来自癌症基因组图谱(Cancer Genome Atlas)。
- 采用逻辑回归模型估计年龄与种族在组织学上的交互作用,采用Cox回归模型估计年龄与种族在生存上的交互作用。
主要发现
- 共分析78,184例白人子宫内膜癌患者和8518例黑人子宫内膜癌患者。
- 浆液性癌和癌肉瘤患者中,黑人诊断年龄中位数较白人年轻3岁(P<0.0001)。
- 非子宫内膜样组织学随年龄增加的表现,黑人患者较白人患者更明显(P<0.0001)。
- 生存和癌症相关死亡的种族差异在黑人较白人、年轻较老年患者中更普遍(P<0.0001)。
- TP53、PTEN突变及三种侵袭性分子亚型各自随种族、年龄和组织学而变化。
临床怎么用
- 作者认为,在早期年龄进行干预可能减轻子宫内膜癌的种族差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although black patients with endometrial cancer (EC) have worse survival compared with white patients, the interaction between age/race has not been examined. The primary objective was to evaluate the impact of age at diagnosis on racial disparities in disease presentation and outcome in EC. METHODS: We evaluated women diagnosed with EC between 1991 and 2010 from the Surveillance, Epidemiology, and End Results. Mutation status for TP53 or PTEN, or with the aggressive integrative, transcript-based, or somatic copy number alteration-based molecular subtype were acquired from the Cancer Genome Atlas. Logistic regression model was used to estimate the interaction between age and race on histology. Cox regression model was used to estimate the interaction between age and race on survival. RESULTS: 78,184 white and 8518 black patients with EC were analyzed. Median age at diagnosis was 3-years younger for black vs. white patients with serous cancer and carcinosarcoma (P<0.0001). The increased presentation of non-endometrioid histology with age was larger in black vs. white patients (P<0.0001). The racial disparity in survival and cancer-related mortality was more prevalent in black vs. white patients, and in younger vs. older patients (P<0.0001). Mutations in TP53, PTEN and the three aggressive molecular subtypes each varied by race, age and histology. CONCLUSIONS: Aggressive histology and molecular features were more common in black patients and older age, with greater impact of age on poor tumor characteristics in black vs. white patients. Racial disparities in outcome were larger in younger patients. Intervention at early ages may mitigate racial disparities in EC.
引用
- Tarney CM, Tian C, Wang G, et al. Impact of age at diagnosis on racial disparities in endometrial cancer patients. Gynecol Oncol. 2017. PMID: 28800945. doi:10.1016/j.ygyno.2017.07.145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。